1.5 Abstract in rivista: [1479] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 721 a 740 di 1.479
Titolo Data di pubblicazione Autore(i) File
Vacop-B vs Vacop-B plus high-dose sequential therapy (HDS) for aggressive non-Hodgkin's lymphoma (NHL) 1-gen-2002 Santini, G; Congiu, A; Olivieri, Attilio; Malolino, I; Chisesi, T; Salvagno, L; Quaini, R; Rubagotti, A; Centurioni, R; Contu, A; Candela, M; Rizzoli, V.
Reduced-intensity conditioning followed by allogeneic transplantation is an effective salvage treatment for patients with hematologic malignancies failing a previous autograft 1-gen-2002 Corradini, P; Tarella, C; Olivieri, Attilio; Dodero, A; Voena, C; Leoni, Pietro; Zallio, F; Ciceri, F; Devizzi, L; Rambaldi, A; Sajeva, M; Bordignon, C; Gianni, A; Bregni, M.
Factors affecting acute toxicity in 294 autologous transplant procedures: a single center multivariate analysis 1-gen-2002 Capelli, D; Montanari, M; Spitaleri, L; Pennacchioni, M; Candela, M; Centurioni, R; Poloni, Antonella; Lucesole, M; Gini, G; Massidda, D; Leoni, Pietro; Olivieri, Attilio
Transplant-related mortality (TRM) in patients receving reduced vs conventional intensity thiotepa-cyclophosphamide (THIO-CY) conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) 1-gen-2002 Busca, A; Bosi, A; Van Lint, M; Guidi, S; Faida, M; Locatelli, F; Tarella, C; Corradini, P; Olivieri, Attilio; Lucesole, M; Pioltelli, F; Pogliani, E; Rotoli, B; Bacigalupo, A.
Long term results of a Multicenter study of autologous selected-PBSC transplantation in advanced CLL patients. 1-gen-2002 Scime, R; Tringali, S; Santoro, A; Di Bella, R; Cavallaro, A; Majolino, I; Musso, M; Olivieri, Attilio; Narni, F; Iacopino, P; Leoni, Pietro; Basirico, R; Mirto, S.
Reduced-intensity conditioning followed by allogeneic transplantation (HSCT) is an effective salvage treatment for both low- and high-grade non-Hodgkin lymphomas: Disease chemosensitivity has a major impact on outcome. 1-gen-2002 Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, Em; Rambaldi, A; Majolino, I; Soligo, D; Scime, R; Gianni, Am
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with Rituximab as frontline therapy for high-risk follicular lymphoma (FL) patients: An interim analysis. 1-gen-2002 Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Liberati, M; Musso, M; Callea, V; Gallamini, A; Patti, C; Pavone, V; Almici, C; Di Raimondo, F; Fioritoni, G; Olivieri, Attilio; Pogliani, Em; De Souza, Ca; Majolino, I; Boccadoro, M; Gianni, Am; Pileri, A; Corradini, P; Tarella, C.
Reduced-intensity conditioning with low dose ATG or alemtuzumab followed by allogeneic PBSC: A salvage therapy with an encouraging response rate and limited toxicity in relapsed/refractory multiple myeloma. 1-gen-2002 Corradini, P; Milani, R; Ciceri, F; Montefusco, V; Peccatori, J; Mariotti, J; Olivieri, Attilio; Soligo, D; Gianni, Am; Perfetti, V; Bregni, M.
Double reinfusion of PBPC after autotransplantation, combined with early G-CSF plus EPO administration, significantly shortens the cytopenia and abolish the transfusional need. 1-gen-2002 Olivieri, Attilio; Spitaleri, L; Gini, G; Montanari, M; Capelli, D; Lucesole, M; Scortechini, I; Poloni, Antonella; Pasquini, R; Masia, Mc; Leoni, Pietro
Long-term results of a multicenter study of autologous selected PBSC transplantation in advanced CLL patients 1-gen-2003 Scime, R; Tringali, S; Santoro, A; Cavallaro, A; Musso, M; Basirico, R; Di Bella, R; Indovina, A; Crescimanno, A; Olivieri, Attilio; Donelli, A.
In multiple myeloma (MM) allogeneic PBSC transplantation results in high rate of remission and low rate of recurrence. 1-gen-2002 Majolino, I; Corradini, P; Santoro, A; Scime, R; Falda, M; Bosi, A; Tarella, C; Musso, M; Olivieri, Attilio; Boccadoro, M; Marceno, R; Pileri, A.
Kinetics of immune reconstitution and incidence of infections following allogeneic peripheral blood stem cell transplantation (PBSCT) in patients conditioned with a reduced-intensity regimen 1-gen-2002 Dodero, A; Peccatori, J; Olivieri, Attilio; Pescarollo, A; Ferreri, A; Rossini, S; Gianni, Am; Bordignon, C; Bregni, M; Corradini, P.
Vacop-B versus Vacop-B plus high-dose sequential therapy for aggressive non-Hodgkin's lymphoma - final analysis of the NHLCSG 1-gen-2003 Santini, G; Olivieri, Attilio; Majolino, I; Congiu, A; Chisesi, T; De Souza, C; Patti, C; Salvagno, L; Quaini, R; Rubagotti, A; Centurioni, R; Contu, A; Candela, M; Rizzoli, V.
Salvage therapy with pegylated lyposomal doxorubicin and rituximab plus GM-CSF in heavily pretreated lymphoma patients relapsing after transplantation 1-gen-2003 Lucesole, M; Capelli, D; Montanari, M; Gini, G; Cecchi, S; Spitaleri, L; Poloni, Antonella; Leoni, Pietro; Olivieri, Attilio
An outpatient model of autologous stem cell transplantation with double peripheral blood stem cell reinfusion and early growth factor administration 1-gen-2003 Olivieri, Attilio; Montanari, M; Capelli, D; Lucesole, M; Spitaleri, L; Scortechini, I; Cecchi, S; Gini, G; Leoni, Pietro
Chimerism evaluation in the lymphoemopoietic subpopulation after allogeneic reduced-intensity stem cell transplantation: a comparison of two different regimens including and not fludarabine 1-gen-2003 Lucesole, M; Poloni, Antonella; Capelli, D; Gini, G; Spitaleri, L; Cecchi, S; Montanari, M; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with rituximab in poor-risk follicular lymphoma: early evaluation on treatment feasibility and response rate 1-gen-2003 Ladetto, M; Ricca, I; Benedetti, F; Liberati, M; Vitolo, U; Musso, M; Gallamini, A; Callea, V; Pavone, V; Almici, C; Di Raimondo, F; De Sousa, C; Fioritoni, G; Majolino, I; Olivieri, Attilio; Patti, C; Pogliani, E; Astolfi, M; Boccadoro, M; Gianni, Am; Corradini, P; Tarella, C.
Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma 1-gen-2003 Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, E; Rambaldi, A; Locasciulli, A; Falda, M; Santoro, A; Scime, R; Gianni, Am
Combination therapy with Caelyx, dexamethasone and thalidomide (CDT) for multiple myeloma (MM): Preliminary results of a phase II-III study. 1-gen-2003 Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Barulli, S; Capelli, D; Rupoli, S; Leoni, Pietro
Reduction of the aplastic phase and hospitalization in patients receiving PBSC autotransplantation followed by erythropoietin plus filgrastim: A matched analysis of 79 consecutive procedures 1-gen-2003 Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Lucesole, M; Gini, G; Cecchi, S; Spitaleri, L; Troiani, E; Masia, Mc; Leoni, Pietro
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 721 a 740 di 1.479
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista1479
Autore
  • OLIVIERI, Attilio158
  • PROVINCIALI, Leandro138
  • SILVESTRINI, Mauro138
  • LEONI, Pietro92
  • EMANUELLI, Monica88
  • POLONI, Antonella79
  • SANTARELLI, Andrea75
  • LUZZI, Simona66
  • SARTINI, Davide61
  • GOTERI, Gaia59
Data di pubblicazione
  • 2020 - 202685
  • 2010 - 2019662
  • 2000 - 2009566
  • 1990 - 1999141
  • 1981 - 198925
Editore
  • BMJ / British Medical Journal Pub...1
  • CSIRO Publishing:150 Oxford Stree...1
  • Elsevier1
  • Elsevier Science Limited:Oxford F...1
  • Mary Ann Liebert Incorporated:2 M...1
  • Oxford University Press:Journals ...1
  • Parthenon Publishing:Richmond Hou...1
Rivista
  • NEUROLOGICAL SCIENCES137
  • BLOOD94
  • BONE MARROW TRANSPLANTATION62
  • HAEMATOLOGICA46
  • ANNALS OF THE RHEUMATIC DISEASES43
  • ITALIAN JOURNAL OF ANATOMY AND EM...40
  • ANTICANCER RESEARCH33
  • ITALIAN JOURNAL OF BIOCHEMISTRY31
  • ACTA OPHTHALMOLOGICA27
  • BIOCHIMICA CLINICA25
Keyword
  • DBS4
  • mortar3
  • STN3
  • brick2
  • DBS STN2
  • geopolymer2
  • IAQ2
  • language disorders2
  • mechanical properties2
  • P3002
Lingua
  • eng955
  • ita108
  • ger1
  • spa1
Accesso al fulltext
  • no fulltext1477
  • open1
  • reserved1